ELV Elevance Health Inc

$321.80

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Elevance Health's upcoming earnings report on October 21 is set against a backdrop of anticipation, particularly as the company navigates the evolving healthcare landscape. With an EPS estimate of $4.94 and a revenue projection of $49.34 billion, the market is keenly observing how Elevance will perform relative to the whisper number of $4.98, which subtly raises the bar for expectations. Despite the absence of recent news, Elevance's substantial market cap of approximately $79.5 billion underscores its significant presence in the industry. Investors will be looking for signs of strategic initiatives that could drive future growth, especially in light of the company's historical performance and the broader market sentiment towards healthcare providers. As the earnings date approaches, the focus will be on whether Elevance can exceed these expectations and deliver results that reflect both operational efficiency and strategic foresight.

Updated On 11/21/2025

About Elevance Health Inc

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Website: https://www.elevancehealth.com

Sector
FINANCE
Industry
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1156039
Address
120 MONUMENT CIRCLE, INDIANAPOLIS, IN, US
Valuation
Market Cap
$96.11B
P/E Ratio
16.53
PEG Ratio
0.76
Price to Book
2.33
Performance
EPS
$25.68
Dividend Yield
1.61%
Profit Margin
3.38%
ROE
14.80%
Technicals
50D MA
$414.38
200D MA
$450.86
52W High
$560.90
52W Low
$360.70
Fundamentals
Shares Outstanding
226M
Target Price
$501.23
Beta
0.78

ELV EPS Estimates vs Actual

Estimated
Actual

ELV News & Sentiment

Nov 21, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint?
TDOC's steady stream of acquisitions is expanding its global reach and lifting growth across key segments in 2025.
Nov 20, 2025 • Zacks Commentary NEUTRAL
Elevance Health ( ELV ) Down 8.4% Since Last Earnings Report: Can It Rebound?
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nov 13, 2025 • Motley Fool SOMEWHAT-BULLISH
The Oncology Institute ( TOI ) Q3 2025 Earnings Call
Image source: The Motley Fool.Thursday, November 13, 2025 at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Nov 11, 2025 • Zacks Commentary SOMEWHAT-BULLISH
CVS Health Lifts Adjusted EPS Outlook: What's Driving It?
CVS raises its full-year EPS outlook after a strong quarter, driven by gains across all segments and solid pharmacy growth.
Nov 05, 2025 • Zacks Commentary NEUTRAL
Humana Beats Q3 Earnings on Premium Growth, Updates 2025 View
HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.
Nov 03, 2025 • Zacks Commentary NEUTRAL
Can Humana Beat Q3 Earnings Estimates on Growing Premiums?
HUM aims for a Q3 earnings beat as rising premiums and solid service revenues offset higher costs and lower income.
Sentiment Snapshot

Average Sentiment Score:

0.139
50 articles with scored sentiment

Overall Sentiment:

Neutral

ELV Reported Earnings

Jul 17, 2025
Jun 30, 2025 (Pre market)
-0.82 Surprise
  • Reported EPS: $7.72
  • Estimate: $8.54
  • Whisper:
  • Surprise %: -9.6%
Apr 22, 2025
Mar 31, 2025 (Pre market)
0.49 Surprise
  • Reported EPS: $11.97
  • Estimate: $11.48
  • Whisper:
  • Surprise %: 4.3%
Jan 23, 2025
Dec 31, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $3.84
  • Estimate: $3.85
  • Whisper:
  • Surprise %: -0.3%
Oct 17, 2024
Sep 30, 2024 (Pre market)
-1.28 Surprise
  • Reported EPS: $8.37
  • Estimate: $9.65
  • Whisper:
  • Surprise %: -13.3%
Jul 17, 2024
Jun 30, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $10.12
  • Estimate: $10.01
  • Whisper:
  • Surprise %: 1.1%
Apr 18, 2024
Mar 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $10.64
  • Estimate: $10.53
  • Whisper:
  • Surprise %: 1.0%
Jan 24, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $5.62
  • Estimate: $5.59
  • Whisper:
  • Surprise %: 0.5%
Oct 18, 2023
Sep 30, 2023 (Pre market)
0.53 Surprise
  • Reported EPS: $8.99
  • Estimate: $8.46
  • Whisper:
  • Surprise %: 6.3%
Jul 19, 2023
Jun 30, 2023 (Pre market)
0.26 Surprise
  • Reported EPS: $9.04
  • Estimate: $8.78
  • Whisper:
  • Surprise %: 3.0%

Financials